These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19899548)

  • 1. [Proliferative retinopathy, friend or foe?].
    Craiu AM
    Oftalmologia; 2009; 53(3):64-72. PubMed ID: 19899548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proliferative vitreoretinopathy].
    Toma C
    Oftalmologia; 2004; 48(3):6-10. PubMed ID: 15598042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal redetachment after silicone oil removal in proliferative vitreoretinopathy: a prognostic factor analysis.
    Lam RF; Cheung BT; Yuen CY; Wong D; Lam DS; Lai WW
    Am J Ophthalmol; 2008 Mar; 145(3):527-533. PubMed ID: 18191093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
    Ahmadieh H; Feghhi M; Tabatabaei H; Shoeibi N; Ramezani A; Mohebbi MR
    Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative vitreoretinopathy.
    Barile G; Chang S; Schiff W
    Ophthalmology; 2007 Sep; 114(9):1794; author reply 1794-5. PubMed ID: 17822994
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy.
    Chang YC; Hu DN; Wu WC
    Am J Ophthalmol; 2008 Sep; 146(3):440-446. PubMed ID: 18599016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal redetachment after silicone oil removal in proliferative vitreoretinopathy: a prognostic factor analysis.
    Mondal S; Hussain N; Natarajan S
    Am J Ophthalmol; 2008 Jul; 146(1):145; author reply 145. PubMed ID: 18573359
    [No Abstract]   [Full Text] [Related]  

  • 8. Proliferative vitreoretinopathy: developments in pathogenesis and treatment.
    Asaria RH; Charteris DG
    Compr Ophthalmol Update; 2006; 7(4):179-85. PubMed ID: 17007731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proliferative Vitreoretinopathy].
    Wiedemann P; Bringmann A
    Klin Monbl Augenheilkd; 2016 Sep; 233(9):1012-5. PubMed ID: 27479581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitrectomy with daunorubicin].
    Raczyńska K; Gebka A; Iwaszkiewicz-Bilikiewicz B; Ciechanowski C
    Klin Oczna; 2004; 106(3 Suppl):481-4. PubMed ID: 15636243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proliferative vitreoretinopathy: pathophysiology and clinical diagnosis].
    Rouberol F; Chiquet C
    J Fr Ophtalmol; 2014 Sep; 37(7):557-65. PubMed ID: 24997864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple retinal detachments: identifying the at-risk case.
    Asaria RH; Gregor ZJ
    Eye (Lond); 2002 Jul; 16(4):404-10. PubMed ID: 12101447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proliferative vitreoretinopathy (PVR) surgery: Scar Wars : Five steps to successful treatment of PVR detachment].
    Priglinger SG; Siedlecki J; Hattenbach LO; Grisanti S
    Ophthalmologe; 2021 Jan; 118(1):18-23. PubMed ID: 33346893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative vitreoretinopathy.
    Tennant MT; Nelson ML; Blade KA; Garg SJ; Lane RG
    Ophthalmology; 2007 Sep; 114(9):1793-4; author reply 1794-5. PubMed ID: 17822991
    [No Abstract]   [Full Text] [Related]  

  • 15. Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology.
    Charteris DG; Sethi CS; Lewis GP; Fisher SK
    Eye (Lond); 2002 Jul; 16(4):369-74. PubMed ID: 12101443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinotomy and silicone oil for detachments complicated by anterior inferior proliferative vitreoretinopathy.
    Tsui I; Schubert HD
    Br J Ophthalmol; 2009 Sep; 93(9):1228-33. PubMed ID: 19429589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinal shortening: the most severe form of proliferative vitreoretinopathy (PVR)].
    Pastor JC; Rodríguez de la Rúa E; Martín F; Mayo-Iscar A; de la Fuente MA; Coco R; Bailez C; Mahave S
    Arch Soc Esp Oftalmol; 2003 Dec; 78(12):653-7. PubMed ID: 14689321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patomechanisms in proliferative vitreoretinopathy.
    Kaczmarek R; Misiuk-Hojło M
    Klin Oczna; 2011; 113(1-3):64-7. PubMed ID: 21853955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin.
    Kumar A; Tewari HK; Bathwal DP; Khosla PK
    Indian J Ophthalmol; 1994 Mar; 42(1):31-5. PubMed ID: 7927629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of rubeosis in association with proliferative vitreoretinopathy (PVR).
    Bourke RD; Cooling RJ
    Retina; 1997; 17(3):262-4. PubMed ID: 9196943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.